GREEN BAY, WI — David Novak, a patient at the Hemophilia Outreach Center, made history as the first Wisconsinite — and only the second person in the nation — to receive the newly FDA-approved gene therapy treatment ROCTAVIAN for hemophilia A. This breakthrough offers hope for reducing or eliminating the need for regular infusions and marks a major milestone for the hemophilia community.
Recognizing the Signs of a Bleed and Knowing When to Act with Angie Farrar
Today on Beyond the Bleeds, Heather is joined by stand-in co-host Erica for a conversation with Angie Farrar, lead nurse coordinator from our Wausau clinic, about recognizing the early signs of a bleed and why acting early matters. From joint bleeds and muscle bleeds...

